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A global review of the expansion of multinational healthcare companies 
 
The commercialisation of public healthcare systems is taking place globally. One dimension of healthcare 
commercialisation is the growing role of multinational healthcare companies.  Increasingly, companies view 
healthcare services as part of a global marketplace, with healthcare provision, high technology healthcare 
equipment, health insurance and pharmaceuticals as sub-markets. The national and regional contexts, within 
which multinational companies operate also, influence expansion strategies. 
 
The nature of healthcare as a product also affects the way in which companies expand.  A recent conference 
on the global healthcare industry expressed how the healthcare industry is seen in relation to other 
industries. 
“Health care industry goods and services differ significantly from those of other industries in one very 
particular way: the product or output of the industry is not often as tangible or measurable. From a 
producer's perspective, and even more so from that of a consumer, health care is an unpredictable 
industry with a hard-to-define output” (AMEinfo, 2003)   
This has sometimes meant that expansion can be a slow process. 
 
Opportunities for private healthcare company expansion depend on the existence of payment systems.  A 
process of costing and pricing of different elements of healthcare underpin commercialisation.  These 
processes are facilitated by the use of information technology (IT) to provide systems for charging, collecting 
payments and organising pricing systems.  Often the first phase of commercialisation involves the 
development of these IT systems.  Many companies are involved in the process of developing a financial 
infrastructure for healthcare. 
 
The expansion of the commercial healthcare markets is strongly influenced by changes taking place in public 
healthcare systems.  The goal of several companies is to expand into public sector markets and this is a 
significant factor in understanding multinational company strategies in Europe. This is often linked to 
companies perceiving themselves as playing a role in reshaping national healthcare sectors (Lethbridge, 
2005).  In countries where the public sector is less strong, private healthcare expansion is more dependent 
on introducing systems of health insurance, which enables high and middle income groups to access private 
healthcare.  Companies are increasingly diversifying into a range of healthcare products and services. 
 
Although healthcare multinational companies are the main players in this process of commercialisation, the 
World Bank and the International Financial Corporation play an important role in enabling the creation of 
financial infrastructure and influencing national governments policies towards the use of multiple providers of 
healthcare.  The World Trade Organization and regional trade organisations, such as the European Union, 
play important roles in encouraging competition necessary for the creation of healthcare markets. National 
competition commissions are also becoming more influential in mediating potential mergers and acquisitions 
of healthcare companies. 
1. Market expansion of healthcare multinational companies 
 
The analysis of the market expansion of healthcare multinational companies will be approached by 
considering the region in which the home countries of multinational companies are located.  This section 
starts by examining the expansion of three multinational companies in Asia, followed by an analysis of trends 
in Africa.  The Americas and Europe follow, illustrating some of the similarities and differences in healthcare 
multinational company expansion.  
 
1.1. Asia 
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One of the aims of health sector reform is to increase the role of private health insurance in the financing of 
health care.  This is supported by the World Bank promotion of a model of basic public services for low 
income groups and private health insurance for middle income groups. In Asia, there are pressures on 
publicly funded systems to focus more on the provision of healthcare for low income groups and to allow 
private sectors insurers and healthcare providers to deliver healthcare to middle income groups (Lethbridge, 
2005). 
 
The experience of multinational companies is shaped by the history of healthcare in the region.  In Asia, 
there is a highly competitive private healthcare market with healthcare companies and government hospitals 
competing for fee-paying patients.  International companies entering this regional market, have to be able to 
respond to a changing market by drawing on their specific experience and expertise to develop products that 
either private patients can afford to buy through health insurance or that governments will be prepared to 
purchase. 
 
Health insurance is targeted at middle income groups often portrayed as a “modern” way to pay for health 
care.  The introduction of co-payments for drugs and certain types of treatment in the public sector can also 
lead people to taking out private health insurance to cover these costs. In other cases, the quality of public 
health services deteriorates so much that people begin to use private sector providers, eventually funded by 
health insurance.   
 
Global insurance companies are beginning to enter national Asian markets.  Multinational healthcare 
companies are aware that an adequate system of health insurance is needed if people are to pay for 
healthcare and enable private healthcare companies to expand their markets.  
 
Another form of international healthcare expansion is through medical tourism, which can be defined as “the 
provision of „cost effective‟ private medical care in collaboration with the tourism industry, for patients 
needing surgical and other forms of specialized treatment (Sen Gupta, 2004).  This process is being 
facilitated by both the corporate sector involved in medical care as well as the tourism industry.  Health 
ministries are also involved.  Many governments are promoting health tourism as a way of drawing in foreign 
exchange. In Asia, India, Malaysia, Singapore and the Philippines are actively promoting medical tourism.  
Private healthcare providers, for example in India, are lobbying governments for subsidies to enable further 
development of medical tourism.  
 
In 2002, the IFC in Investing in private health care sees its main role as contributing “to the financial 
protection against ill health and to strengthening of the middle class” (IFC, 2002).  The IFC states that  
“because of the structure and financing mechanisms of health care systems, (it) cannot directly 
target the poor but rather gives loans to institutions that work with the lower-middle and middle class 
groups”.(IFC, 2002) 
 
In Asia, IFC investments are concentrated in high technology and hospital healthcare projects.  Two types of 
Asian companies are partners in these investments: a) specific Asian healthcare companies e.g. Apollo 
Group of India; 2) conglomerates e.g. Lopez Group, a large diversified conglomerate in the Philippines.  A 
recent loan to the Max Healthcare company in India is for the development of a range of healthcare facilities 
at primary, secondary and tertiary levels which is unusual in its focus on primary care facilities. 
 
Three companies, Apollo, Parkway Holdings and Columbia Asia Healthcare will now be discussed to 
illustrate the range of different forms of expansion that are taking place in Asia. 
 
Comparison of 2006 revenues for three companies 
 
Company Country of 
origin 
Operations 2005-6 2006-7 
Apollo India Sri Lanka, 
Bangladesh, 
Nigeria, Kuwait, 
Yemen 
7691Rs in Mio 9,566 Rs in Mio 
Parkway Holdings Singapore Malaysia, India, 
Brunei 
Darassulam  
S$563,616,000 S$868,004,000 
 
Columbia Asia 
Healthcare  
Malaysia Vietnam 
India, Sri Lanka, 
Indonesia 
n/a n/a 
Sources: Apollo Annual Report (2006); Parkway Holdings Ltd Full year Financial Holding Statement 
http://www.parkwayholdings.com/Business/docs/71826260207financialstatement.pdf 
n/a = not available 
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Apollo 
Apollo Hospitals Enterprise Limited was incorporated as a Public Limited Company in 1979.  Apollo owns 
and manages 41 hospitals and is the largest healthcare provider in Asia.  The hospital services are 
predominantly high technology, tertiary services.   It was the first company to develop private corporate 
healthcare, with the foundation of a hospital in 1987 in Chennai.  Large business groups, for example, the 
Tata Group, had been involved in hospital provision before then, but had set up trusts, which could benefit 
from charitable status, rather than establish corporate entities. The Apollo group was also the first company 
to involve non-resident Indian doctors in medical care investments.  Governments provided subsidised land 
and duty free import of medical equipment.   
 
Apollo runs nursing and hospital management colleges, pharmacies, diagnostic clinics, medical transcription 
services, managed care administration and telemedicine. In 2007, it established a joint health insurance 
company, with DKB, a European company, which is an example of a company expanding into both health 
insurance and healthcare provision (Health Insurance News, 2007).  Apollo is also developing companies 
that delivery outsourcing, IT services and project management consultancy.  In December 2004 it 
announced that it was negotiating a contract for medical business process outsourcing with a New York 
teaching hospital.  This will include billing and coding operations and claims processing (Apollo Hospitals, 
2007).   It is also involved with telemedicine, education and training, home healthcare and hospital project 
management.  
 
As well as owning hospitals, Apollo also manages hospitals in Nigeria, Kuwait, Yemen, Sri Lanka and 
Bangladesh.  Although the company is involved in delivery of healthcare services internationally, through 
hospital management, it is increasingly providing healthcare for international patients from Tanzania, the 
USA, the UAE, Kenya, Oman and neighbouring Asian countries through medical tourism.   
 
Parkway Holdings 
Parkway Holdings is a multinational Singapore based company that operates hospitals, healthcare centres 
and laboratories in Singapore, Malaysia, Indonesia and India.  Parkway Holdings sees government services 
as potential competition and so is trying to position itself towards the market for high income patients.  In this 
sense, Parkway is trying to develop its own niche rather than meeting the needs of the public sector.  
However, it is also taking advantage of the Singapore government‟s policy of outsourcing some clinical 
services. 
1
  
 
Parkway has also started to run its own managed care programme, which combines insurance with the 
provision of care, in a joint venture with Allianz, a large European insurance company. Parkway now has 
40,000 members in Singapore and is hoping to expand this programme to Malaysia and Indonesia in the 
future.  It is currently finding out how many members are needed to break even, and is targeting „high end‟ 
patients. Parkway views the expansion of private health insurance and private health services as 
complementary market processes.
2
   
 
The company is also investing in new hospitals in India and Brunei Darassulam. In India, Parkway Holdings 
through its unit Gleneagles Development had made a shareholders agreement with Apollo Hospitals 
Enterprise Ltd from which Apollo had acquired Duncan Industries 50% stake in Duncan Gleneagles hospital 
in Calcutta, India.  The new hospital is seen as the “central health hub for Bangladesh, Myanmar and 
Bhutan” (India Business Insight, 2002). 
 
Parkway Holdings also attempted to expand into the Malaysian market by becoming a shareholder (31.3%) 
of Malaysian-listed Pantai Holdings in 2005.  This was reduced to 28.5% by 31 December 2005. Pantai 
operates, and has equity stakes in, 7 hospitals in Malaysia (yawning bread, 2006). The Malaysian State 
investment company, Kazanah Nasional, was also involved in this acquisition.  This deal created political 
tensions in Malaysia because privatised state companies should only include no more than 30% foreign 
ownership.   
 
The eventual agreement was that Parkway Holdings sold its direct stake in Pantai Holdings Bhd. to Kazanah 
Nasional, the state-owned investment company.  Parkway took a 49% stake in a joint venture company with 
Khazanah, now owning all Pantai shares. The deal allowed Khazanah to increase its investments in 
healthcare after it bought a stake in Apollo Hospitals, India's largest private healthcare provider, in 2005. 
Parkway will continue to manage the Pantai hospitals (Dow Newswires, 2006). This involvement of Parkway 
Holdings in the Pantai Group illustrates another form of expansion, through the development of joint 
ventures, with a government investment agency.   
 
 
Columbia Asia Group 
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Columbia Asia Group is a healthcare company which was set up as  Columbia Pacific Healthcare, as a joint 
venture between the Chemical Company of Malaysia Berhad and Columbia Pacific Management (CPM), 
based in Seattle, Washington, USA.  It has hospitals in Malaysia, Vietnam and India with plans for expansion 
into Sri Lanka and Indonesia (Association of Private Hospitals of Malaysia, 2007).  
 
Columbia Asia Sdn Bhd is 30% owned by the Employees Provident Fund Malaysia (EPF), which is a social 
security organisation set up by the Malaysian government to provide retirement benefits to private sector 
employees and non-pensionable public service employees. Other shareholders include Columbia Asia 
Pacific Healthcare and several doctors. It involves non-resident Indian doctors in healthcare investments 
(Columbia Asia, 2007). 
 
In India, Columbia Asia Partner programme work with leading medical insurers and other managed care 
administration arrangements. The company also has formal agreements with leading Life Insurance 
companies and offer pre-insurance medical tests for their clients.  These insurance arrangements do not 
seem to be in place in Malaysia or Vietnam.  The company is not active in health tourism, although according 
to it website, it is interested in exploring opportunities (Columbia Asia, 2007).  
 
Table 2 : Types of expansion : Asia    
 
Company Building 
hospitals 
Acquisitions Joint ventures Medical 
tourism 
Health 
insurance 
IT services for 
health finance 
Apollo YES YES YES YES YES YES 
Parkway 
Holdings 
- YES YES YES YES - 
Columbia Asia 
Group  
YES YES - - YES - 
 
1.2. Africa 
 
In Africa, there are more limited opportunities for private healthcare sector expansion.  There has not been 
the same expansion of middle income groups, necessary for the growth of private healthcare, as found in 
Asia. However, there are some signs that private sector companies are beginning to be more involved in the 
creation of health insurance and managed care systems.  The role of the International Finance Corporation 
(IFC) has been more limited than in Asia.  IFC loans have been primarily for hospital construction with only 
one investment in health insurance.  
 
Although there has been an expansion of private healthcare in South Africa, the market has reached 
saturation point.  This has led to South African healthcare companies expanding into the United Kingdom.  
 
Table 3: Revenues of three healthcare companies: Africa 
 
Company Home country Operations   2005 2006 
Life (formerly Afrox) South Africa Botswana, 
UK 
US$ 275m   
Netcare South Africa UK 7,353Rm 8,184Rm 
AAR Health 
Services 
Kenya Tanzania, 
Uganda  
  
 
Sources: 
Life/Afrox BOC (2005) 6-K SEC filing http://sec.edgar-online.com/2005/11/17/0001276754-05-000014/Section2.asp 
Netcare (2006) Audited Group Results http://reports.netcareinvestor.co.za/prelim_06/ 
 
Afrox/ Life Healthcare 
Afrox Healthcare (Afhealth) was listed on the JSE in October 1999 after African Oxygen created the largest 
private health-care group, from its existing health services.    Until 2005, Afrox was majority-owned by the 
global BOC Group.  In 2003, Bidco, a broadbased black empowerment consortium made a bid for Afrox 
Healthcare.  Brimstone and Mvelaphanda, both black empowerment groups, together with a countrywide 
selection of healthcare empowerment groupings owned 75% of Bidco. The remaining share was to be held 
by Medi-Clinic who, together with holding company Remgro, provided funding support to the offer (Afrox 
Healthcare, 2003). 
 
However, Netcare, one of the largest healthcare companies in South Africa, challenged the deal on 
competition grounds and the South Africa Competition tribunal ruled on the case.  Netcare‟s concerns were 
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focused on the involvement of MediClinic, another healthcare company.  Eventually, Mediclinic withdrew 
from the deal, leaving Bidco as owner of company in January 2005. Bidco agreed to pay all of the R70 
million plus costs that were incurred by both Mediclinic and Netcare in the prolonged investigation before the 
competition authorities (Bonorchis, 2005; Competition Commission, 2005) .  
 
This acquisition by Bidco has created the largest black owned healthcare company in South Africa, now 
called Life Healthcare.  The company delivers a wide range of healthcare services in South Africa.  It 
provides acute care through 62 centres in South Africa and Botswana.  Through a public-private partnership, 
Life healthcare delivers rehabilitation services to district hospital and health services on contract to provincial 
governments.  Life Healthcare is the largest private provider of mental health services in South Africa.  Life 
Healthcare also provides doctors and specialists with IT systems and business support to help with practice 
management (Life Healthcare, 2008).   
 
Life provides occupational health services to the private sector, mines and prisons.  Life Mining healthcare 
provides health services to the mining sector.  Life has also, through a joint venture with Farani Health 
Solutions been awarded a contract to provide and manage health services at a maximum security prison in 
Bloemfontein.  A new division has been set up to focus on correctional services.  The joint venture company 
has also secured a contract for occupational health services for the Industrial Development Zone in Port 
Elizabeth (Life Healthcare, 2008)  
 
In a joint venture with Care UK, the Partnership Health Group UK, Life provides services to National Health 
Service (NHS) patients in the United Kingdom.  Life Healthcare provides nurses and management at several 
intermediate treatment centres, which provide services for the NHS (Life Healthcare, 2008).  
 
Netcare 
Netcare is listed on the Johannesburg Securities Exchange and has grown from four hospitals in 1996 to a 
current total of 62 hospitals.  The group also owns and manages Medicross, which runs family medical and 
dental centres in South Africa.  It also runs 43 pharmacies and 36 administered practices (representing a 
further 114 general practitioners). In addition, Netcare also provides emergency services, pathology 
services, renal care and travel clinics.   
 
Netcare also holds interests in a training academy for nurses.  Netcare was awarded the first Public private 
partnership (PPP) contract to a consortium consisting of Netcare and black-empowerment company 
Community Hospital Management (CHM) for Universitas and Pelonomi Hospitals in Bloemfontein.  It owns 
Prometheus Solutions, which provides IT for healthcare management (Netcare, 2007). The Netcare Group 
employs 16,574 staff.  
 
Netcare International operates in the UK and the Middle East as a healthcare management company.  A 
significant expansion for Netcare, was it entry into the British healthcare market in 2002, becoming a 
provider of healthcare services to reduce  NHS waiting-lists, through the Independent Sector Treatment 
centre programme, funded by the UK Department of Health.  The company is currently fulfilling a five-year 
contract to perform 44,500 cataract operations for the NHS via mobile services. The Greater Manchester 
Surgical Centre (GMSC) is a newly built facility attached to the Trafford General Hospital where specialists 
from Netcare UK perform elective orthopaedic, ENT and general surgical procedures (Apax Partners Private 
Equity Group, 2006).   
 
In 2006, Netcare acquired, with funds advised by Apax Partners Worldwide LLP, London and Regional 
Properties and funds advised by Brockton Capital LLP the General Hospital Group (GHG)in the UK. Netcare 
will own 50.1% of GHG in return for an investment of approximately £217m, along with the injection of its 
wholly owned UK subsidiary Netcare Healthcare UK Limited. Netcare cited the limited opportunities for 
acquisition in South Africa as the reason for the General Health Group purchase (Apax Partners Private 
Equity Group, 2006). 
 
Netcare owned 43.75% of a South African company, Community Healthcare Group.  In 2007, the South 
Africa Competition Commission approved Netcare‟s purchase of the remaining 56.25% of the shares, in 
August 2007.  Netcare is also planning to sell its pathology division, Ampath (Netcare Healthcare Holdings 
Ltd, 2007).  
 
In September 2007, Netcare announced that it was considering the sale of its UK property portfolio sale 
03/09/2007 “Netcare chief financial officer Peter Nelson has been quoted as saying the company will 
consider selling its UK property portfolio, in order to achieve a better value for its UK main business before 
any share sale. The JSE-listed healthcare group is reportedly prepared to sell all the properties, which 
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include 35 hospitals and 2,122 beds, under the right conditions. The property sale will formally go to the 
market in September” (Business Sale Report, 2007). 
 
Netcare, as seen through an account of a Strategy Day in August 2007, thinks that there will be a reduction 
on of resources for the UK NHS which will lead to rationing and the introduction of user fees.  The company 
sees opportunities for the development of personal medical insurance, following the decrease in resources 
going into the NHS (netcare Healthcare Holdings Ltd, 2007). This illustrates how private companies, 
providing healthcare to a publicly funded system, also consider possibilities for an expansion of private 
healthcare.  
 
AAR  
AAR Health Services Limited was originally an air rescue health service. As a managed care company 
operating in Kenya, it received an IFC loan in 1998 to support its expansion into other East African countries.  
One of the founders of AAR was Bengt Beckmann, who was also a founder of Medicover, a healthcare 
company operating in Eastern and Central Europe (AAR Health, 2007). 
 
In 2004, the company gained a new shareholder: the Acacia Fund, one of the funds managed by CDC 
Capital, the privatised investment arm of the UK government investment development company 
Commonwealth Development Corporation.  This is another example of how national government investment 
companies are becoming involved in healthcare investments (Lethbridge, 2005).  
 
However, in May 2004, the company sold 35% of its shares to Project Ventures International, a company 
dealing with health and information technology in several counties in Africa. This took place at the same time 
as the Kenyan Government has proposed a new national health insurance scheme, which had to potential to 
affect private healthcare providers because companies will no longer have to provide healthcare insurance 
for their employees (Wandera and Njeru, 2004).  Government policies can have a significant impact on 
private companies.  
 
AAR has expanded in Eastern Africa, using a franchise model of both preventive and curative services. The 
franchise package entitles suitably qualified institutions to have access to an e-commerce-based computer 
software package, together with diagnostic, treatment, referral, laboratory, drug, customer care and 
accounting protocols. This package enables non-health companies to develop and deliver services 
themselves.  Five franchise health centres have been set up in Tanzania, Uganda and Kenya (AAR Health, 
2007).   AAR is one of the few IFC investments in Africa over the past decade that has been directly involved 
in the development of a health insurance company.  The progress of this investment shows how finance 
capital is becoming involved in health insurance, albeit in a cautious way.  
 
Table 4: Types of expansion: Africa    
 
Company Building 
hospitals 
Acquisitions Joint ventures Medical 
tourism 
Health 
insurance 
IT services for 
health finance 
Afrox/ Life 
healthcare 
- - YES - YES YES 
Netcare YES YES YES - YES YES 
AAR - - YES - YES YES 
 
1.3. Americas 
 
In the United States, by the 1990s, healthcare companies started to face financial problems because of 
higher medical costs, higher than expected Medicare costs, and an increasingly competitive market (Jasso-
Aguilar et al, 2004.  Premiums were not high enough to cover the increasing costs.  By 1998 the rate of profit 
in the managed care market had slowed from 8% to 1.2% (Vranges, 1998).    
 
With declining profits, healthcare companies started to merge.  Larger companies were considered to be in a 
stronger position to drive down the costs of doctors and hospitals but this has not happened.  The market for 
older people‟s healthcare and Medicare has proved less profitable than companies expected.  The Balanced 
Budget Act (1997) placed further financial pressure on many large healthcare companies because it placed 
limits on spending; only allowing annual premium increases of 2%.  Share values dropped and healthcare 
companies started to move out of unprofitable areas, such as Medicare and Medicaid (Jasso-Aguilar et al, 
2004).  
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Many healthcare companies attempted to move into markets perceived to be more profitable. The Latin 
American market, where social insurance systems were being privatised, appeared to offer higher rates of 
profit Jasso-Aguilar et al, 2004).  US health insurance companies such as Cigna and Aetna, both moved into 
Latin American markets but retreated within five years, when profits started to fall. By 2000, Aetna had sold 
its international division to ING, a Dutch insurance company.  Cigna sold its operations in Brazil in 2003. 
 
Some large healthcare companies experienced fall in profits and either filled for bankruptcy and were 
financially restructured, for example, Tenet, HCA, and Sun Healthcare.  The Balanced Budget legislation, by 
limiting expenditure for Medicare and Medicaid, exposed some of the fraudulent practices that the 
companies had established to claim Medicare and Medicaid costs.   There are indications that large 
healthcare companies are still involved in exploiting Medicare and Medicaid payments.  Several renal care 
companies are currently under investigation for over-charging Medicare for Vitamin D and diagnostic tests 
(American Health Line, 2005). 
 
In 2007, there are signs that the US healthcare system is becoming unsustainable with levels of debt rising 
to 12% of company turnover. The fastest levels of debt increases are for people with health insurance.  As 
the costs of health insurance increase, employers and employees are choosing plans where more costs are 
passed onto the patient or are not taking out health insurance at all (Bowe, 2007).  The capacity of 
healthcare companies to continue to expand will be restricted by the increase in debt.    
 
Table 5: Company revenues Million$ 2004-2006 United States 
 
Company Country Operations 2005 2006 
United Health 
Group 
United States United 
Kingdom 
? ? 
HCA United States UK, 
Switzerland 
$24,455 $25,477 
Cigna United States South Korea, 
Taiwan, 
China, New 
Zealand, 
Indonesia,  
Thailand, 
United 
Kingdom, EU, 
Chile  
$15,332 $16,547 
Sources: 
United Health Group 10-K 2005 
HCA 10-K 2005, 2006 
Cigna 10-K 2005, 2006 
 
United Health Group 
United Health Group is a US for-profit healthcare services company.  In 1984, United HealthCare 
Corporation became a publicly traded company.  Perhaps one of the most significant changes, in the last 
decade, was when the company changed its name from the United HealthCare Corporation to the United 
Health Group.  It reorganised the company into separate but strategically linked business areas.  The 
company has expanded into business areas that complement the provision of health insurance and 
healthcare services. This parallels the trend in several healthcare companies in Asia and Africa. 
 
These services and products reflect many of global trends in commercialised healthcare (Pollock, 2004; 
Lethbridge, 2005).  They can be considered as different stages of a vertically integrated industry.  The key 
stages include insurance schemes to provide financing to cover the costs of healthcare, and information 
technology used to check patient eligibility, payments and billing systems, data management systems for 
practitioners, as well as access to healthcare services through doctors and other healthcare professionals.   
The company employs 55,000 people in the United States (United Health Group, 2005).   
 
United Health Group is gradually providing a much wider range of products than health insurance and 
healthcare.  It is positioning itself as a healthcare company that aims to improve the healthcare system.  It 
describes its mission as “dedicated to making the health care system work better” which makes it appealing 
to other national healthcare systems that are involved in health sector reform.  The company also stresses its 
role in “designing products, providing services and applying technologies”.  The significance of applying 
technologies lies not just in the use of high technology treatments for patients but in using technology to 
maintain control over payments, billing and eligibility of patients to healthcare. 
 
In 2004, United Health Group set up a European wholly owned subsidiary, whose mission is “to help 
European health services improve patient care”.  The Chief Executive Office is Richard Smith, until recently 
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editor of the BMJ. The European President is Simon Stevens, previously an adviser to the Policy Unit, 10 
Downing Street.  The Chief Operating Officer is Gail Marcus who had 20 years of working in healthcare and 
pharmacy management companies, including CIGNA, a large US health insurance company (United Health 
Group, 2007). 
 
The first stage in the United Health Group expansion into the UK has been the involvement of Evercare in a 
pilot scheme with the Department of Health, which aims to keep frail, older people out of hospital.  In October 
2006, United Healthcare Europe was awarded a five year contract to run a GP practice in Normanton in 
Derby (unison, 2006).  It is one of the first Alternative Provider Medical Services (APMS) contracts, which 
allow PCTs to contract out the running of primary care services to a wide range of provider organisations. 
 
The company has a recent history of complaints and legal suits made under two US laws: the Employees 
Retirement Income Security Act (ERISA), a US federal law that sets minimum standards for retirement and 
health benefit plans in private industry; and the Racketeer Influenced and Corrupt Organizations Act (RICO), 
which is used for civil claims by individuals injured in business or property by companies involved in 
corruption or illegal activities United Health Group, 2004).  
 
In 2006, the Securities and Exchange Commission launched an enquiry into the stock option grants operated 
by United Health Group and found that the accounts published by the company for 2004 and 2005 could “no 
longer be relied on”.  Several senior managers of the company were found guilty of increasing the price of 
stock options (United Health Group, 2006).  
 
HCA 
In 2001, HCA owned and operated 184 hospitals (172 general/ acute care, 6 psychiatric hospitals and 6 
hospitals included in joint ventures, 79 free standing surgery centres). These were located in 24 states of the 
US, England (6 hospitals) and Switzerland (2 hospitals). 
 
In July 1997, there were Federal investigations into the business practices of the company.  Since 1997 it 
has reduced the numbers of hospitals by 42% (144) and the number of surgical centres by 48%.  The 
company sold most of its home health operations and non-core assets.  It also spun off LifePoint Hospital 
and Triad Hospital to create 2 public traded companies, which operate 57 hospitals.  In December 2000 HCA 
completed the sale of 116 medical office building to MedCap Properties.  In May 2000 Columbia/HCA 
changed its name to HCA – The Healthcare Company and a year later to HCA Inc.  
 
In 2006 HCA entered merged with the Hercules Acquisition Corporation, a subsidiary of Hercules Holding 
which is owned by a private investor group including Bain capital, Kohlberg Kravis Roberts, Merrill Lynch 
Global private equity, and affiliates of the HCA founder Dr. Thomas F. Frist. Following this merger, the 
company has a $28,408 billion debt.  HCA has 186,000 employees, 49,000 part time(HCA, 2006). 
 
Cigna 
Cigna Corporation provides life, accident, and supplementary health insurance products and international 
healthcare products and services.  Cigna International operations are located in South Korea, Taiwan, 
China, New Zealand, Indonesia, Thailand, United Kingdom, European Union, and Chile.  In 2006, it sold its 
Brazilian life assurance business.   
 
In 2007, it was reported that CIGNA International had appointed three people to sales and management 
positions to capitalise on the "growth opportunities of the European healthcare market (Health Insurance and 
Protection, 2007).  
 
The United States healthcare market is in crisis. The major healthcare companies are not showing any signs 
of significant international expansion.  Several North American companies have been awarded preferred 
bidder status for the United Kingdom NHS Intermediate Treatment centres.   These suggest that US 
companies are entering the UK market through joint ventures and partnerships.  Ascent Health Ventures, 
which was formerly Johnson and Johnson Health Care Systems ASG, is one of several partners with 
Mercury Health, which will run 9 treatment centres in England.  Anglo-Canadian Clinics is a consortium of 
Calgary Health Region and University of Calgary Medical Group, Surgical Centres Inc, which runs private 
surgery clinics in Alberta.  Other consortium members include several housing and construction companies. 
Nations Healthcare is a US company that runs day surgery centres (UNISON Bargaining Support, 2003). 
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Table 6: Types of expansion: American companies   
 
Company Building 
hospitals 
Acquisitions Joint ventures Medical 
tourism 
Health 
insurance 
IT services for 
health finance 
United Health 
Group 
- YES YES - YES YES 
HCA - YES - - YES YES 
Cigna - YES - - YES YES 
1.4. Europe 
 
Many European healthcare companies see European and other global opportunities for expansion in 
different aspects of the healthcare sector: insurance; clinical and diagnostic services; and facilities 
management services.  Partnerships with the public sector are seen, by many companies, as an essential 
step towards developing and delivering new services and facilities. The involvement of these companies, in 
the delivery of services in the public healthcare sector, will have implications for health workers and for the 
accountability of public health systems.   
 
Many companies view their relationships with government/ public healthcare sector as crucial to future 
company growth.  Some companies are building up their experience of working with the public sectors.  
There are several examples in Europe of governments contracting private companies to manage a public 
sector hospital.  In some countries this also involves the private company in building the hospital.  Global 
service companies have been involved in private finance initiatives in the UK. 
 
Expansion into Central and Eastern Europe by healthcare companies has been slow, although two 
companies, Medicover and Euromedic International, have continued to expand since 2004.  Euromedic 
International is now expanding into Western Europe.   
 
Table 7: Company Revenues Europe 
 
Company Home country Activities 2005 2006 
Alliance Medical  UK, Italy, 
Netherlands, Poland 
  
BUPA United Kingdom Spain, Thailand, 
Malaysia, 
£3,8778m £4,245m 
Capio Sweden Sweden, Finland, 
Norway, Denmark, 
UK, France, Spain, 
Germany  
  
Cinven UK Spain, Portugal   
Euromedic 
International 
Hungary Bosnia- Herzo-
govina,  Croatia, 
Czech Republic, 
Greece, Hungary, 
Ireland, Portugal, 
Poland,  Romania, 
Russia, Turkey 
  
Fresenius Germany Austria, Belgium. 
France, Germany, 
Italy, Sweden, UK,  
Spain 
€7,889m €10,000m 
Medicover Hungary Estonia, Czech 
Republic, Hungary, 
Poland, 
Romania 
  
Jose de Mello Saude  Spain, Brazil   
 
Alliance Medical Group 
The Alliance Medical Group provides a range of high technology services, such as PET, MRI, CT, and 
mammography services.  It provides extensive, outsourced mobile services as well as fixed site services.  
The company was formed in 1989 by Robert Waley-Cohen, who had previously co-founded Alliance Imaging 
Inc. in the USA in 1983. The company started to operate in the UK in 1990.  In 1996, a management buyout 
was backed by 3i plc and Foreign & Colonial.  Bridgepoint bought out 3i and Foreign and Colonial in 2000.  
Since 2003, the company has continued to win contracts from the NHS.  The company runs two Intermediate 
Treatment Centres in the UK with the Partnership Health Group in SW England and provides equipment for 
at least 19 hospitals with hospitals in the UK.     
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There has been some criticism of the quality of services delivered by Alliance Medical in the UK, including 
mistakes in the interpretation of images and delays in the delivery of results.  Doctors in Belgium, South 
Africa and Spain interpret the data and do not collaborate with doctors in the NHS (BBC, 2005).  There have 
also been questions asked in Parliament about the contacts between Alliance Medical and the Department 
of Health in the period before one contract was awarded in 2004.  In January 2007, Alliance Medical, in 
partnership with Care UK, was awarded preferred bidder status to provide diagnostic services across the 
North East of England.  The service will be delivered under a joint brand name of AMC Diagnostics Limited 
(Alliance Medical;, 2007).  
 
 
BUPA 
BUPA is one of the two largest providers of private health insurance in the UK with 40.1% of the market.  In 
the last 10 years BUPA has expanded through a series of acquisitions in the UK and worldwide.  Its most 
striking area of expansion has been into care services.  BUPA Care Services consist of the three 
subsidiaries: BUPA Nursing Homes ltd, BUPA Care Services Ltd and Care First Group plc.   BUPA runs 223 
care homes, 54 sheltered retired homes and in 1999 cared for 26,000 people in residential care or through 
home care services.  BUPA has also expanded into nursing and other care services (BUPA, 2008). 
 
In 2007, BUPA sold its 25 hospitals to Cinven for £1.44 billion, in order to pay off debt and to focus on long 
term development of the company, internationally and in the care sector.  This is a dramatic change for 
BUPA, which has been one of the leading private sector healthcare providers in the UK.  BUPA also 
operates in Spain, Middle East, Thailand, Hong Kong, Singapore and Malaysia.   
 
BUPA Ireland was established in June 1996 but was sold to the Quinn Group in March 2007.  This was due 
to the imposition of the Risk Equalisation Scheme (RES), which would have involved selling double the 
anticipated surplus to the State owned insurer VHI (BUPA, 2007). 
 
Sanitas is a Spanish health insurer and healthcare provider and was incorporated into BUPA in 1989.  In 
September 2006, Sanitas, won a government tender to build and run a large new public hospital in Manises, 
Valencia.  The 15 year PFI contract for the Valencia government involves building and managing the new 
hospital as well as updating and running primary care centres in the region, building a new health centre in 
Turis and renovating a specialist centre in Aldaya.  Sanitas has formed a consortium with Ribera Salud, 
(Sanitas 60%: Ribera Salud 40%), which is owned by Bancaja and Caja Mediterraneo, two Spanish banks 
(RiberaSalud, 2007).  The project is worth €137 million.   The Horta Manises hospital will employ 700 staff 
and treat 140,000 people in the province. Sanitas has two other hospitals, both in Madrid (BUPA, 2006). 
 
In 2007, the Sanitas group acquired Sanitas Residencial, BUPA Group‟s Spanish care home provider, has 
bought the Euroresidencias‟ care home and day centre portfolio from the Spanish company Saarema 
Inversiones.  This will make Sanitas, the second largest provider of long term care in Spain. 
 
BUPA entered Thailand in 1996 when it joined with Blue Cross. Blue Cross was a Thai company founded 
over thirty years ago that became Blue Cross in 1985.  BUPA Blue Cross is a provident association, which 
reinvests profits into the business.  BUPA Blue Cross has between 65% and 80% of the Thai health 
insurance market.   The company has contracts with 119 hospitals and about 100 clinics.  It provides 
insurance coverage for at least 1,500 firms and 8,000 individual members (Bangkok Post, 2002; The Nation 
(Thailand), 2002).  Although BUPA Blue Cross has a large percentage of the health insurance market in 
Thailand, it is in competition with life insurance companies that also sell health insurance policies as part of 
their life packages.    
 
BUPA has been expanding into both health insurance and healthcare provision in Asia over the last few 
year.  In 2001, BUPA bought Vista Healthcare in Asia which has contributed to BUPA‟s expansion in the 
Asia market.  In 2002, BUPA together with Macquarie Bank bought AXA Asia Pacific Holdings, a health 
insurance in Australia.  It is now the third largest private health insurer in Australia.  BUPA owns half the 
business. In 2006, BUPA established a Representative Office in China (BUPA, 2006). 
 
Capio 
Capio is a Swedish healthcare company, which is aiming to become a trans-European healthcare company.  
Since 2003, Capio has continued its expansion into France, Spain and Germany, as well as consolidating its 
provision of services to the public sector in Sweden, Norway, Denmark, Finland, Spain and the UK. 
 
One of the most significant developments since 2004, was the sale in September 2006, of Capio to Opica, a 
company “indirectly jointly owned by Apax Partners Worldwide LLP, by Nordic Capital Fund VI and by funds 
advised or managed by Apax Partners SA”.  The company was delisted in November 2006. 
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In 2005, Capio acquired the Grupo Sanitario IDC (Spain), its first entry into the Spanish healthcare market. It 
also sold the Clinique Saint Vincent (France) and closed the Dreux clinic in France.  The same year, it also 
sold La Metairie clinic in Switzerland (Capio, 2006).  
 
In 2006, Capio made expanded significantly into the French healthcare market, by buying the Arvita Hospital 
Group, Clinique La Rochelle and Clinique Saint Jean Languedoc, and the Tonkin Group.  It also achieved 
one of its goals to enter the German healthcare market, by acquiring the Deutsche Klinik (Capio, 2006). 
 
Since 2004, Capio has achieved its goals of moving into Spain and Germany as well as consolidating its 
presence in France and the UK.  It has also negotiated longer contracts at St. Gorens, Sweden  and 
Valdemoro, Spain with public authorities.  The contract for Valdemoro, Madrid, is a contract on a capitation 
basis, which provides an annual fixed payment per head of population.  The contract involves building a 
hospital, which is expected to open at the end of 2007 (Capio, 2008). 
 
In January 2007, Capio Diagnostics was merged into Capio UK.  There are two hospital laboratories in the 
UK, which will be transferred to Capio UK. The aim is to build a decentralised pathology services, outside the 
Capio health care business, especially at ‟point of care‟ testing (Medical Laboratory World, 2007).  In August 
2007, Capio bought Unilabs, a Swiss based laboratory company, which activities in UK, France, Spain, Italy, 
Russia and Portugal.  It will merge Unilabs with Capio Diagnostics (Capio, 2008).  
 
In May 2007, a property consortium, including property entrepreneurs Nick Leslau and Sir Tom Hunter 
agreed to buy the property portfolio of 21 private hospitals in the United Kingdom from Capio, worth £686m.  
They will be leased back to Capio (Brodie, 2007).  In June 2007, Opica was given permission by the 
European Commission to sell Capio UK (Unison Companies Update, 2007). This follows an earlier 
announcement that Capio UK was to become independent.   Opica bought Capio on condition that it sold the 
UK hospitals, “to avoid regulatory problems” (Unison Companies Update, 2007). In September 2007, Capio 
sold its English acute hospitals to Ramsay Health Health Care Limited, an Australian company, which 
operates 65 hospitals in Australia and three in Indonesia (Capio, 2008).  The mental health and laboratory 
services will remain with Capio. 
 
Cinven 
Cinven, as a European private equity investor, has over a decade of experience of investing in healthcare 
companies.  In 2005, it bought Partnerships in Care from the General Health Group.  Partnerships in Care 
provide mental health services, specialist units for people with learning disabilities, brain injury rehabilitation 
units, community placements for supported living and an employee assistance programme.  Cinven had also 
invested in the General Health Group, which it sold in 2000 (Cinven, 2008). 
 
In 2007, it has made two significant healthcare investments.  It bought 25 hospitals from BUPA  and also 
bought a Spanish private hospital group, USP Hospitales Group, from Mercapital, a Spanish private equity 
group.  USP Hospitales Group is the leading independent operator in the Spanish private healthcare market 
and second largest provider to the private healthcare insurance market.  Cinven is aiming to expand the 
company through more acquisitions in Spain and in international markets.  USP has recently acquired a 25% 
stake in HPP, the fourth largest hospital group in Portugal.  Caixa Geral owned the remaining 75% of HPP 
(Cinven, 2007). 
 
These two recent acquisitions, suggest that Cinven has identified the European healthcare sector as an 
important source of investment.  Spain is considered to have a fast growing healthcare sector. Cinven has 
also built up some expertise in healthcare management over the past decade.  
 
Euromedic International 
Euromedic Diagnostics BV and International Dialysis Centre BV are both 100% owned Dutch subsidiaries of 
Euromedic International NV, a holding company of the group (Euromedic International Group, 2007).  For 
more than a decade, Euromedic has been building and operating imaging diagnostic centres and dialysis 
centres in Eastern and Central Europe.  They work in public-private partnership arrangements, where 
Euromedic invests in the centres and the public healthcare system pays for the service.  
 
The history of Euromedic International provides an insight into the way in which healthcare companies are 
beginning to operate within a European market.   In 1991, two Hungarian entrepreneurs set up a company 
called International medical Centres in Budapest, which was owned by an Israeli company, Elbit.  In 1995, 
the Euromedic group of companies was set up with the Red Sea Group, also an Israeli company.  In 1998, 
these International Medical Centres merged with the Euromedic group.  In 1999, GE Capital and Dresdner 
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Kleinwert Benson back the founders of Euromedic in a buyout from Elbit.  Euromedic International is formed 
(Euromedic International Group, 2007).  
 
The following year, 2000, further capital was raised, underwritten by the Washington DC based company 
Global Environment Fund.  Euromedic International expanded into Poland, Bosnia – Herzogovina and 
Romania, opening up dialysis clinics. In November 2002, GE Capital and Dresdner Kleinwert Benson bought 
the Red Sea Group.  In 2005, Warburg Pincus and GE Healthcare and management bought out the three 
financial investors.  With support from the Dutch ING bank, they finance the company‟s growth plan, moving 
from Central and Eastern Europe to become a European- wide healthcare provider.  In 2006, Euromedic 
International expanded its activities and moved into Russia, Czech Republic, Greece and Turkey.  In 2007, it 
achieved a pan-European position by expanding into Italy, Portugal and Ireland (Euromedic International 
Group, 2007). 
 
Fresenius 
Fresenius is a “global health care company with products and services for dialysis, the hospital and the 
medical care of patients at home” (Fresenius, 2007).   As a vertically integrated renal care company, 
Fresenius produces products and equipment for renal dialysis and runs dialysis clinics.  The company is 
becoming more involved in the production of infusion therapies for patients at home as well as for a wider 
range of conditions than renal care, e.g. cancer care.   
 
The Fresenius Chairman pointed out in 2001 that there was the potential for Fresenius ProServe, the 
international management division, to expand because “health systems, not only in Germany but all over the 
world, are in a state of change which is marked by increasing privatisation of hospitals and the demand for 
qualified, economically-efficient care of patients” (Krick, 2001). Krick predicted that in Germany the current 
7% of hospitals operated privately will increase and there will also be an increase in integrated hospital 
services where primary and secondary care are brought together. 
 
Developments since 2004, show that Fresenius has continued to expand its healthcare management 
business.  In 2005, Fresenius (ProServe, the healthcare management division) bought the HELIOS group, a 
German private hospital group, which has 55 hospitals and 26,000 employees.  The Wittgensteiner Klinken 
Group, which Fresenius bought in 2001, has been integrated into the HELIOS group.  In 2006, Fresenius 
bought the HUMAINE clinic group, with 6 hospitals and 2,900 employees (Fresenius, 2006).  
 
There are signs that the integration of HELIOS has not been so smooth.  The Herbolzhein hospital, Freiburg, 
has been returned to the local government, after being privatised and bought by the HELIOS group.  Ver-di  
considered that HELIOS were not interested in providing services for the local population.  Since the 
introduction of a pricing system, using diagnostic related groups (DRG), which involves payment for a 
condition rather than for specific treatments,smaller hospitals have been unable to compete successfully with 
larger hospitals.  Ver-di also accused HELIOS of “chaotic management” (Ver.di, 2006).
3
  
 
HELIOS made an agreement with Marburger Bund in December 2006 (Fresenius, 2006:45).  The Fresenius 
2006 Annual Report also reported that there has been a group-wide wage tariff agreement with ver.di for 
14,000 employees at 24 clinics, starting from 1 January 2007.  It has now established a European Company 
(SE) with workers participation on the board of the company. 
 
Fresenius, through VAMED, its international hospital projects division, has become involved in public-private 
partnerships in Austria and Bosnia Herzogovina in Europe.  In Austria, the projects involve clinics and a 
radiology centre.  In Bosnia, VAMED is modernising the University Hospital at Tuzla and building a new 
medical centre at Banja Luka.  VAMED is also contracted to deliver technical management for the Vienna 
General Hospital and manages the non-medical services contact for the Charite University Hospital, Berlin.  
It is also contracted to deliver technical management at Eppendorf University Hospital, Hamburg (Fresenius, 
2006). 
 
Fresenius Medical Care, the dialysis clinics division, bought the Renal Care Group, a company providing 
kidney dialysis, in the United States in 2006, thus expanding its presence in North America (Fresenius, 
2006:18). In the United States, Fresenius Medical Care has recently acquired the Renal Care Group, a 
company that provides renal dialysis. This will strengthen the renal dialysis division of Fresenius.  68% of 
company revenue comes from North America.  Fresenius is currently under investigation in the United States 
for over-charging Medicare for Vitamin D drugs and diagnostic tests that are given to patients being 
assessed for renal dialysis (American Health Line, 2005).   
 
In Latin America, Fresenius has recorded an expansion of activities in the last year, even though the 
contribution to revenue is only 4%.  Dialysis services contributed about 66% of revenues in Latin America.  In 
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Argentina, the largest market in Latin America, over 6,600 patients were treated in 88 dialysis clinics 
(Frensenius, 2004).  It also records that the Brazilian market is more difficult because reimbursement for 
dialysis is low.  Fresenius is unable to run its own clinics because international companies are not, at 
present, allowed to run their own clinics (Fresenius, 2004). However, the company sold over half of all 
dialysers in Brazil, playing an important role in providing equipment and supporting drugs for dialysis.  
Fresenius also has dialysis patients in Colombia and Venezuela.  It provides dialysis products in Peru and 
Chile (Fresenius, 2004).  In 2006, reimbursement rates had increased in Latin America (Fresenius, 2006). 
 
Medicover 
Medicover was established in 1995 by Oresa Ventures, a Swedish venture capital company.  The company 
offers both medical insurance and a health care delivery system, to its clients. Medicover employs most of its 
physicians directly and provides health care through its own facilities.  Medicover provides health insurance 
for corporations and individuals, and delivers health care services through health centres staffed by its own 
doctors and nurses, and on-site workplace facilities for large employers (Medicover, 2007). 
 
In 2005, Medicover bought two laboratories in Poland (Wroclaw and Lodz) and a private hospital in Warsaw.  
It also bought 40% in Centrum Medyczne Damiana in Poland, a provider of clinical and hospital services.  
The company also rebranded its laboratory services, Medicover Rombel, and renamed them Synero in 
Poland and Romania.  In Poland, Synero has several outsourcing contracts from public hospitals.  Medicover 
also provides laboratories and logistics for clinical trials for sites in Poland, Czech Republic, Hungary, 
Slovakia, Romania, Lithuania, Latvia, Russia and the UK (medicover, 2005). 
 
In 2006, Medicover was bought by Celex SA, whose owner was also Chairman of Medicover, Jonas af 
Jochnick, who originally owned 35% of Medicover shares.  The company was delisted in 2006. 
 
Jose de Melle Saude 
Jose de Mello Saude is part of the De Mello group, a large Portuguese holding company.  The healthcare 
company has 976 beds distributed between three hospitals – Amadora Sintra, CUF Infante Santo and CUF 
Descobertas.  It has been involved with a public-private partnership in Sintra. It has recently entered the 
Spanish market by buying 35% of Hospital Group Quiron, a Spanish private hospital group. (Jose de Mello 
Saude, 2007). 
 
In 2000, the company invested, together with the International Finance Corporation and the Icatu Group, in 
Icatu Health Services in Brazil.  The investment covered companies for home care, hospital management 
and health insurance (Jose de Mello Saude Brasil, 2007).  
 
Table  Types of expansion: European companies 
 
Company Building 
hospitals 
Acquisitions Joint ventures Medical 
tourism 
Health 
insurance 
IT services for 
health finance 
Alliance 
Medical 
- YES YES - - - 
BUPA YES YES YES - YES - 
Capio - YES YES - - - 
Cinven - YES YES - - - 
Euromedic 
International 
YES YES YES - YES YES 
Fresenius YES YES YES - - - 
Medicover  YES YES - YES YES 
Jose de Mello 
Saude 
YES YES YES - YES YES 
 
2. Conclusion 
 
There are some common patterns of expansion among healthcare multinational companies throughout the 
world.  There is a move towards diversifying away from just delivering healthcare to providing health 
insurance and other financial infrastructure.  The importance of setting up new methods of financing private 
healthcare can be seen in Asia, and this is starting in Africa. 
 
In Asia, medical tourism is a growing expansion strategy but does not appear to be developing on the same 
scale in other regions.  In Africa, the South African market has expanded at a faster rate than elsewhere, but 
is showing signs of saturation.  South African companies have had to expand away from Africa, into Europe. 
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There is some evidence that there are small scale investments taking place in Africa, in health insurance and 
managed care.   
 
European healthcare companies appear to be the most active, especially in comparison to American 
healthcare companies. European companies are taking advantage of new opportunities to deliver healthcare 
to the public healthcare sector in Europe.  Several companies have identified the need for high technology 
equipment in public health systems.  Partnerships have been developed with national health systems.  The 
ownership of European healthcare companies is changing and becoming dominated by private equity 
investments, which look for a faster return on investments.  They also provide less information about 
company financial affairs.  
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